"
Team:RAMNOTIREN CALGARY
From 2014hs.igem.org
| Line 25: | Line 25: | ||
} | } | ||
| - | + | #box1 { | |
position: relative; | position: relative; | ||
left: -50px; | left: -50px; | ||
| Line 36: | Line 36: | ||
} | } | ||
| - | #box1 h2{ | + | #box1 h2 { |
padding: 10px 0px 0px 350px; | padding: 10px 0px 0px 350px; | ||
text-align: center; | text-align: center; | ||
| Line 42: | Line 42: | ||
} | } | ||
| - | #box1 p{ | + | #box1 p { |
padding: 0px 50px 0px 50px; | padding: 0px 50px 0px 50px; | ||
font-family: arial, verdana, "lucida sans"; | font-family: arial, verdana, "lucida sans"; | ||
Revision as of 20:52, 13 June 2014
Choking Cancer
Every year approximately eight million people die of cancer, and an additional fourteen million are diagnosed with the disease. The World Heath Organization predicts that without immediate action these numbers will increase by eighty percent by the year 2030.
Cancer needs an abundant source of oxygenated blood to grow. To achieve this cancer cells release angiogenic factors that promote vascular growth. Without these factors, cancer is unable to survive. Consequently, current treatments focus on targeting/inhibiting the angiogenic factors released by cancer cells. Targeted therapy has also been a successful treatment option.
Our project aims to combine these two therapeutic approaches to create a synthetic biological machine that seeks out cancer cells and inhibits angiogenesis. We plan to design a bacterium that in the presence of cancer cells secretes an anti-angiogenic factor. This will inhibit the growth of the capillary system that is crucial for cancer cell survival.
